European House Dust Mite (Der p 11) IgE

If you already know dust mites bother you, this test looks at one small, rarely examined piece of that allergy. It measures your immune reaction to a single muscle protein from the European house dust mite, a component that only a minority of dust mite allergic people respond to, though it shows up more often in some groups, such as people with eczema. Knowing your level here tells you whether your allergy has spread beyond the usual handful of triggers.

This is a research-grade marker, not a routine one. Most of what allergists rely on comes from a few major dust mite proteins, and this one sits at the far edge of the picture for airway allergy. That makes it more useful for understanding the full shape of your allergy than for driving any single decision on its own.

What This Test Actually Measures

The full name is Der p 11 (a paramyosin-like muscle protein from Dermatophagoides pteronyssinus, the European house dust mite). The test measures IgE, an antibody your immune system builds when it treats a harmless protein as a threat. These antibodies are made by immune cells called plasma cells, and the blood test reports how much of this specific antibody is circulating.

A positive result signals that your body has become sensitized to this particular mite protein, part of what scientists call a type 2 allergic response, the same immune pathway behind hay fever, asthma, and eczema. A low or absent result simply means your immune system has not built antibodies to this component, which is the far more common finding in people whose dust mite allergy affects the airways.

Where Der p 11 Fits in the Dust Mite Picture

Dust mites carry dozens of different proteins, and your immune system does not react to all of them equally. Researchers sort these proteins into tiers based on how often people's blood IgE binds to them. In studies of respiratory allergy and general populations, Der p 11 sits in a low-prevalence group that usually appears only after the immune system has already reacted to the bigger players.

Source: Posa et al. (German birth cohort, 2017); Thomas (2018); Gonzalez-Perez et al. (atopic dermatitis cohort, 2021).

In a German birth cohort followed to age 20, sensitization typically started with the major proteins Der p 1, 2, and 23, and only later, and rarely, extended to Der p 11. But the prevalence of Der p 11 sensitization varies widely by population, disease phenotype, and testing method. Some studies in specific groups have found much higher reactivity, so the "minor" label is not universal: one study of mite-sensitive asthmatic children reported IgE binding to Der p 11 in about 78%, and a small group of dust mite allergic patients showed roughly 64% reactivity. Read alongside that variability, a positive Der p 11 is best interpreted in the context of who you are and what other components you react to, rather than as a common or central finding.

Asthma and Hay Fever Risk

The clearest signal from the research is about breadth, not this one protein. People whose immune systems react to many dust mite components, including late-appearing minor ones like Der p 11, carry a higher risk of mite-related hay fever and asthma than people who react to only one or two proteins. The reactions to the major components (especially Der p 23) do most of the predictive work; Der p 11 on its own has not been shown to drive asthma or rhinitis risk.

What this means for you: a positive Der p 11 usually rides alongside strong reactions to the major components. Seeing it can flag that your dust mite allergy is wide-ranging, which is worth confirming by looking at the whole component pattern rather than acting on this single number.

Atopic Dermatitis (Eczema)

Dust mite allergy is common in eczema, and this is where Der p 11 may matter most. A study designed specifically to test its role (Banerjee et al., 2015) found that Der p 11 qualifies as a major allergen among dust mite allergic patients who have atopic dermatitis, even though it stays a minor allergen in people whose allergy is limited to the airways. Other cohorts have reported much lower figures: in one group of 80 eczema patients under heavy dust mite exposure, Der p 11 IgE appeared in fewer than 4% of people, and a component panel that left Der p 11 out still correctly identified more than 97% of the dust mite allergic patients. Taken together, Der p 11's relevance depends heavily on the population and disease phenotype, and it may carry more weight in atopic dermatitis than in respiratory allergy alone.

Reading a Positive Result

It helps to think of Der p 11 as a phenotype marker rather than a good-number or bad-number gauge. A positive result reflects how broad your immune response has become, and in some people it may point toward an eczema-linked pattern, but it does not tell you how severe your symptoms will be. No study has shown that the size of a Der p 11 reading predicts disease severity, so the value comes from context: what it tells you when read next to your major-component results and your actual symptoms.

Why Tracking Matters More Than One Reading

Because Der p 11 is a newer, exploratory marker without standardized cutpoints, a single number carries limited weight. Getting a baseline and repeating it later gives you your own trend line to compare against as the science matures. Since the immune response tends to broaden toward minor components over years, repeat testing can be informative, but no study has established an optimal retesting interval for this specific component, so timing should be guided by your allergist and any change in symptoms rather than a fixed schedule.

One caution on tracking whether immunotherapy is working: the evidence that treatment shifts mite IgE comes from whole mite extract and major components, not Der p 11 specifically. If you retest this marker after starting therapy, interpret any change carefully, because its response to treatment has not been directly measured.

What to Do With an Unexpected Result

If Der p 11 comes back positive, read it in context rather than in isolation. Order or review the major components (Der p 1, Der p 2, Der p 23) and total IgE to see whether this reflects broad polysensitization to dust mites. Then match the pattern against your symptoms, because sensitization without symptoms does not equal allergy.

An allergist can weigh whether your overall component pattern supports immunotherapy and whether skin prick or provocation testing is worth doing to confirm which mite reactions are clinically relevant. Der p 11 itself rarely changes that plan in airway allergy, but it can be a useful piece of a fuller workup, particularly when eczema is part of the picture.

When a Reading Can Mislead You

• Silent sensitization: a positive result does not confirm you are allergic, since many people carry mite IgE without ever having symptoms.
• Method and lab differences: blood tests can underestimate dust mite IgE compared with molecular methods, and numbers vary between labs, so a low reading is not always reassuring.
• No established variability figure: there is no published coefficient of variation (a measure of how much a result naturally bounces around) for this specific component, so treat small changes between tests cautiously.
• Everyday factors: kidney function, fasting, and time of day have not been shown to shift this marker, so you do not need to prepare in any special way.